Flame Biosciences Funding: $112M Raised, Series A (2020)
Flame Biosciences has raised $112M in total funding. Latest round: Series A. Backed by Rock Springs Capital, T. Rowe Price Associates, Inc..
Flame Biosciences funding overview
Flame Biosciences has raised $112M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series A announced in September 2020. The round record for Flame Biosciences runs through 2020; nothing later has been disclosed. Investors on record include Rock Springs Capital, T. Rowe Price Associates, Inc., Cormorant Asset Management LP, Janus Henderson Investors, Surveyor Capital, Samsara BioCapital and 4 others. 10 distinct backers are named across the disclosed rounds.
Flame Biosciences at a glance
Total raised
$112M
Latest round
Series A
Latest round date
September 2020
Notable investors
Rock Springs Capital, T. Rowe Price Associates, Inc., Cormorant Asset Management LP, Janus Henderson Investors, Surveyor Capital, Samsara BioCapital, Adage Capital Management LP, Terra Magnum Capital Partners
Frequently asked about Flame Biosciences funding
How much has Flame Biosciences raised?
Flame Biosciences has raised $112M in total disclosed funding across the rounds on record.
Who has invested in Flame Biosciences?
Rock Springs Capital, T. Rowe Price Associates, Inc., Cormorant Asset Management LP, Janus Henderson Investors, Surveyor Capital, Samsara BioCapital are named among the investors backing Flame Biosciences.
What was the latest Flame Biosciences funding round?
The most recent disclosed round is a Series A, announced in September 2020.
Where is Flame Biosciences based?
No headquarters location is disclosed for Flame Biosciences.
When did Flame Biosciences last raise?
The last disclosed Flame Biosciences round closed in September 2020 at Series A.
Every Flame Biosciences figure above comes from filings and announced rounds in the StartupFundraising company database and is revised as new rounds are recorded. The lists below compare companies at a similar stage.
